State Street reports 5.04M shares (6.3%) of Veracyte
State Street Corporation reported beneficial ownership of 5,043,590 shares of Veracyte Inc. common stock, representing 6.3% of the class as of 03/31/2026.
Rhea-AI Filing Summary
State Street Corporation reported beneficial ownership of 5,043,590 shares of Veracyte Inc. common stock, representing 6.3% of the class as of 03/31/2026. The filing lists shared voting power of 4,800,493 shares and shared dispositive power of 5,043,590 shares. The filing identifies several State Street advisory subsidiaries as holders of the position.
Positive
- None.
Negative
- None.
Insights
Large passive holding reported by State Street; position exceeds 5% threshold.
State Street Corporation discloses beneficial ownership of 6.3% (5,043,590 shares) in Veracyte Inc. in a Schedule 13G filed for the period ending 03/31/2026. The position is reported with shared voting and shared dispositive power.
Filing lists multiple State Street advisory vehicles (SSGA Funds Management, State Street Global Advisors Europe Limited, et al.) as relevant subsidiaries. The disclosure is routine for institutional investors reporting passive ownership once the >5% threshold is crossed; subsequent activity will appear in amended schedules if holdings change.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficial ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does State Street report in Veracyte (VCYT)?
Which State Street entities are identified in the Schedule 13G for VCYT?
Does the Schedule 13G indicate whether State Street is an active or passive investor in VCYT?
What voting and dispositive powers does State Street report for its VCYT holding?
AI-generated analysis. How Rhea-AI works. Not financial advice.